<DOC>
	<DOCNO>NCT02222181</DOCNO>
	<brief_summary>In Brazil , patient Alzheimer 's disease ( AD ) receive free drug government . Even access , little known effectiveness , safety adherence drug therapy group patient . The research aim promote adherence develop strategy address Drug-Related Problems ( DRP 's ) AD patient elderly reference centre Elderly Araraquara . The clinical parameter assess begin educational intervention period April 2014 April 2015 .</brief_summary>
	<brief_title>Impact Pharmacotherapy Management Patients With Alzheimer 's Disease</brief_title>
	<detailed_description>Dementia characterize memory loss associate cognitive impairment , directly interfere learn process , social professional performance , besides main cause dementia Alzheimer 's disease ( AD ) . In Brazil , patient medicate AD `` Programa de Medicamentos Excepcionais '' ( Exceptional Drug Program ) ensure patient´s treatment provide high cost medication . Even access , little known effectiveness , safety adherence drug therapy group patient . The research aim promote adherence develop strategy address Drug-Related Problems ( DRP 's ) AD patient . For end , intend conduct descriptive , almost experimental longitudinal uncontrolled research , April 2014 December 2015 , CRIA : `` Centro de Referência Idoso de Araraquara '' ( Reference Centre Elderly Araraquara ) . Patients include research must diagnosis AD must use drug supply `` Programa de Medicamentos Excepcionais '' . For data collection pharmaceutical care employ technique , carry pharmaceutical meeting , include step initial assessment , care plan ( pharmaceutical intervention ) result evaluation . The result monitor pharmacotherapy adherence , cognitive assessment clinical parameter related health problem resolution DRP 's propose follow-up.The expect outcomes include knowledge medication experience AD patient , influence adherence DRP 's contribute solving problem , addition impact evaluation pharmaceutical care cognitive improve clinical parameter monitor evaluate individually .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Elderly patient assist CRIA , diagnose Alzheimer 's use rivastigmine donepezil galantamine , assist `` Program special drug '' . Be resident city Araraquara / SP Accept part pharmacotherapeutic followup ; Sign Statement Informed Consent Form ( ICF ) . Fold pharmacotherapy followup ; Being institutionalize ; Patients unable respond collection instrument MMSE CDR data ; Patient without phone contact .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>elderly , medication adherence , pharmaceutical care</keyword>
</DOC>